NCT00830349View on ClinicalTrials.gov

Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions

PHASE1CompletedINTERVENTIONAL
Enrollment

30

Participants

Timeline

Start Date

June 30, 2001

Primary Completion Date

July 31, 2001

Study Completion Date

July 31, 2004

Conditions
Healthy
Interventions
DRUG

Risperidone

1 mg Tablet

DRUG

Risperidone

1 mg Tablets

Trial Locations (1)

G1V 2K8

Anapharm Inc., Sainte-Foy

All Listed Sponsors
lead

Teva Pharmaceuticals USA

INDUSTRY

NCT00830349 - Risperidone 1 mg Tablet in Healthy Subjects Under Fasting Conditions | Biotech Hunter | Biotech Hunter